Clue, the Berlin-based period and cycle tracking app, has announced a strategic investment from Verdane, a European growth equity firm. The specific amount was not disclosed, but the company describes it as a substantial contribution from Verdane’s €2 billion growth fund and the single largest investment in Clue to date. Verdane will become the largest investor in the company.
Clue says it has over 100 million downloads worldwide and is available in 23 languages across more than 190 countries. The investment follows what the company describes as an exceptional 2025 that created a path to long-term profitability.
The funding will support product innovation and feature development, global expansion, healthcare partnerships, clinical research, privacy and security measures, and personalization technology.
“Women are the world’s largest health and wellness consumers, controlling the majority of household spending in every market, yet they remain strikingly underserved relative to their economic power,” said Rhiannon White, CEO at Clue. “This gap creates three systemic pain points: a profound lack of accessible female health knowledge that forces women to self-diagnose, a confusing marketplace filled with unproven products and little evidence-based guidance, and persistent barriers to accessing care. For businesses, this represents not just a social issue but a significant market failure and a compelling opportunity to build trusted, data driven solutions that meet the needs of the most influential spenders in global health and wellness.”
White added: “Partnering with Verdane enables us to accelerate the creation of this powerful ecosystem and tackle these issues for women. Verdane’s deep expertise in growing sustainable businesses, combined with their extensive operating experience in the health and wellness space means they bring unparalleled support to the opportunity in front of us.”
Christina Stoll, Principal at Verdane, said: “We are highly impressed by the Clue management team and the strong momentum the business is demonstrating. Clue has earned exceptional user trust by combining the highest data protection standards with rigorous, science-based insights in a category where credibility truly matters. Consumer demand and awareness for trusted women’s health solutions continues to accelerate, and Clue is uniquely positioned to lead this space.”
Stoll added: “Clue’s women-led, mission-driven approach and focus on meaningful impact strongly align with what Verdane stands for.”
Verdane is a certified B Corporation and has raised over €9 billion in capital since 2003. The firm is based in Berlin, Copenhagen, London, Helsinki, Munich, Oslo, and Stockholm.
